Pediatric Hematology and Oncology
- Administrative/ Clinical Title:
- Division Chief, Pediatric Hematology/Oncology
ROBERT PARKER MD
PEDIATRIC ACUTE MYELOID LEUKEMIA (AML)
PEDIATRIC BLEEDING DISORDERS
PEDIATRIC BONE CANCER
PEDIATRIC BRAIN CANCER
PEDIATRIC BRAIN TUMORS
PEDIATRIC HODGKIN'S LYMPHOMA
PEDIATRIC NON-HODGKINS LYMPHOMA
PEDIATRIC RESEARCH TRIALS (CLINICAL TRIALS)
AFFINITY HEALTH PLAN
CIGNA GREAT WEST HEALTHCARE
EMPIRE BLUE CROSS HMO
EMPIRE BLUE CROSS OTHER PLANS
EMPIRE BLUE CROSS PPO
EMPIRE BLUE CROSS SENIOR PLAN
FIDELIS CARE NEW YORK
ISLAND GROUP ADMINISTRATION
NEIGHBORHOOD HEALTH PLAN
SUFFOLK HEALTH PLAN
UNITED EMPIRE PLAN (NYSHIP)
UNITED OXFORD FREEDOM PLAN
US FAMILY HEALTH PLAN
VYTRA (except SMART START)
Education & Training
- Medical Degree:
- Brown University, RI
- Pediatrics, Rhode Island Hospital - Brown University, RI
National Institute of Health, MD
Rhode Island Hospital-Brown University, RI
Academic & Other
- Year Appointed at
(1)Resident Teaching Award for Best Subspecialist Teacher: 1993-94, 1994-95
(2)Elected to AOA by SUNY at Stony Brook School of Medicine Senior Class in recognition of teaching and dedication: 1998
(3)Chosen one of the 100 most influential alumni of Brown University in the 20th Century - 2000
(4) Selected for inclusion in New York Magazine's Best Doctors 2010 listing.
(5) One of the "Doctors of Excellence" featured in the 2012 editions of the Castle Connolly Guides,
Top Doctors:New York Metro Area ,America's Top Doctors for Cancer, and America's Top Doctors.
3 EDMUND D PELLEGRINO RD,
(1)Parker RI and Gralnick HR: Energy dependent expression of platelet von-Willebrand factor on the surface of unstimulated and stimulated platelets. J Lab Clin Med 130:520-529, 1997.
(2)Mahgoub N, Parker RI, Hosler MR, Close P, Shannon KM, Felix CA: RAS mutations in pediatric leukemias with MLL gene rearrangements. Genes Chromosomes and Cancer 21:270-275, 1998.
(3)Parker RI, Siegal RS, Ratajczak M, Gewirtz AM: Deficient In Vitro megakaryocytopoiesis and decreased In Vivo platelet turnover in children and young adults with chronic thrombocytopenia. J Ped Hematol/Oncol 20:196-201,1998.
(4)Felix CA, Hosler MR, Slater DJ, Parker RI, Masterson M, Whitlock JA, Nowell PC, Lange, BJ: MLL genomic breakpoint distribution within breakpoint cluster region in de novo leukemia in children. J Ped Hematol/Oncol 20:299-308, 1998.
(5)Parker RI, Prakash D, Giugliano D, Mahan RA, Atlas M: A randomized double-blind cross-over placebo-controlled trial of intravenous ondansetron for the prevention of post-intrathecal chemotherapy induced vomiting in children. J Ped Hematol/Oncol 23:578-581, 2001.
(6)Ancona K, Parker RI, Atlas M, Prakash D: A randomized trial of high dose methylprednisolone vs. IV-IgG for the treatment of acute ITP in children. J Pediatr Hematol/Oncol 24:540-544, 2002.
There are 700 + physicians and other health care providers practicing within 18 different clinical entities, or specialty groups that are affiliated with Stony Brook University Physicians (SBU Physicians). Together, these providers offer patients of all ages a comprehensive range of high quality medical services, from primary care to advanced specialty care. The physicians and health care professionals affiliated with SBU Physicians are committed to excellence in service and leadership in clinical care. In their capacity as faculty of the Stony Brook University School of Medicine, they also educate medical students, interns, residents and fellows in many specialties and sub-specialties, and engage in research and clinical trials that help to advance the science of medicine.
These physicians and health care professionals are committed to excellence in service and leadership in clinical care for their patients. SBU Physicians supports and coordinates this mission and maintains this website for patients, physicians and staff.